June 5 (Reuters) - CSL Ltd (CSL) :
- INJECTAFER APPROVED IN U.S. FOR TREATMENT OF IRON DEFICIENCY IN PATIENTS WITH HEART FAILURE
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$253.90 |
Change
-3.480(1.35%) |
Mkt cap ! $123.0B | |||
| Open | High | Low | Value | Volume |
| $256.32 | $256.50 | $252.60 | $50.03M | 196.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 15 | $253.87 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $253.93 | 71 | 5 |
View Market Depth
| Last trade - 11.52am 21/07/2025 (20 minute delay) ? |
| CSL (ASX) Chart |